LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 217 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,843,000 | +23.1% | 14,000 | -7.1% | 0.57% | +16.1% |
| Q2 2018 | $3,121,000 | -10.1% | 15,066 | -28.3% | 0.49% | -14.9% |
| Q1 2018 | $3,471,000 | +83.4% | 21,017 | -4.9% | 0.58% | +92.7% |
| Q3 2015 | $1,893,000 | -31.1% | 22,100 | -18.9% | 0.30% | -6.8% |
| Q2 2015 | $2,748,000 | -21.4% | 27,236 | -40.0% | 0.32% | -20.3% |
| Q1 2015 | $3,498,000 | +225.4% | 45,367 | +162.8% | 0.40% | +98.0% |
| Q2 2014 | $1,075,000 | -37.7% | 17,264 | -32.7% | 0.20% | -34.4% |
| Q1 2014 | $1,725,000 | +11.7% | 25,654 | -12.6% | 0.31% | +12.7% |
| Q4 2013 | $1,544,000 | +21.4% | 29,362 | -0.1% | 0.28% | +8.7% |
| Q3 2013 | $1,272,000 | -57.1% | 29,397 | -62.9% | 0.25% | -60.6% |
| Q2 2013 | $2,967,000 | – | 79,291 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |